Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 37Carcinoma, Non-Small-Cell Lung 28Glioblastoma 24Brain Neoplasms 23Esophageal Neoplasms 20Rectal Neoplasms 19Stomach Neoplasms 17Glioma 17Lung Neoplasms 16Colorectal Neoplasms 16Astrocytoma 14Pancreatic Neoplasms 12Central Nervous System Neoplasms 12Squamous Cell Carcinoma of Head and Neck 10Neoplasm Metastasis 10Head and Neck Neoplasms 10Gliosarcoma 10Sarcoma 9Oligodendroglioma 9Recurrence 8Neoplasms 8Adenocarcinoma Of Esophagus 8Esophageal Squamous Cell Carcinoma 7Uterine Cervical Neoplasms 6Ovarian Neoplasms 6Colonic Neoplasms 6Pilonidal Sinus 5Melanoma 5Carcinoma, Ovarian Epithelial 5Adenocarcinoma of Lung 5

Interventions

Gemcitabine 20Cisplatin 13Paclitaxel 8Carboplatin 8Docetaxel 5Radiotherapy 4Doxorubicin 4aflibercept 3Vinblastine 3Ramucirumab 3Methotrexate 3Fluorouracil 3vinflunine 2pembrolizumab 2Trastuzumab 2Sunitinib 2Platinum 2Neoadjuvant Therapy 2Ifosfamide 21,2-diaminocyclohexaneplatinum II citrate 2vandetanib 1tipifarnib 1temsirolimus 1rubitecan 1piritrexim 1pegfilgrastim 1pazopanib 1lonafarnib 1ixabepilone 1eribulin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Urethral Neoplasms × Surgical Procedures, Operative × Clear all
NCT00045630 2013-05-27

S0219, Combination Chemotherapy Followed By Observation or Surgery in Patients With Stage II or Stage III Cancer of the Urothelium

SWOG Cancer Research Network

Phase 2 Completed
77 enrolled 11 charts
Genitourinary

Urinary Bladder Neoplasms, Urethral Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡